Adverse cognitive effects of medications: turning attention to reversibility

JAMA Intern Med. 2015 Mar;175(3):408-9. doi: 10.1001/jamainternmed.2014.7667.

Authors

Noll L Campbell¹, Malaz A Boustani²

Affiliations

¹ Purdue University College of Pharmacy, West Lafayette, Indiana2Department of Pharmacy, Eskenazi Health, Indianapolis, Indiana3Indiana University Center for Aging Research, Indianapolis4Regenstrief Institute, Indianapolis, Indiana.
² Regenstrief Institute, Indianapolis, Indiana5Department of Medicine, Indiana University School of Medicine, Indianapolis6Department of Medical Quality, Indiana University Health, Indianapolis.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cholinergic Antagonists / administration & dosage*
Cholinergic Antagonists / adverse effects*
Dementia / epidemiology*
Female
Humans
Male

Substances

Cholinergic Antagonists

Grants and funding